Document:

Exhibit 10.2

 

Confidential

 

September 19, 2013

 

Navidea Biopharmaceuticals, Inc

425 Metro Place North, Suite 300

Dublin, OH 43017

 

Attention: Mark Pykett, Chief Executive
Officer

 

 

		Re:	Engagement with JMP Securities LLC

 

Dear Mark:

 

We are pleased to confirm
the terms upon which JMP Securities LLC (“JMP”, “we” or “us”) is engaged by Navidea Biopharmaceuticals,
Inc. (“you” or the “Company”) as the sole placement agent with respect to a purchase of $30 million of
common stock by Crede Capital Group, LLC (the “Transaction”). That “Transaction” constitutes a Transaction
for the purpose of the agreement. This letter will confirm the understanding and agreement between JMP and the Company (the “Agreement”).

 

You are engaging us
as the placement agent for a direct placement common stock and warrants of the Company (the “Securities”) in the Transaction.
The proposed terms of the Transaction will depend on the outcome of our due diligence investigation and market conditions and the
actual terms will be subject to negotiations between the Company, us and Crede Capital Group, LLC. The Company will be responsible
for the preparation and contents of all legal documents to effectuate the Transaction. These materials will furnish all information
required to be disclosed or furnished to investors under applicable securities laws and will not contain any untrue statement of
material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.

 

You may in your sole
discretion postpone, modify or abandon a Transaction prior to closing. Either of us may decline to participate in a Transaction
if we reasonably determine that the Transaction has become impractical or undesirable. Unless we have notified you in writing of
our decision not to participate, you will not make any commitment with any other securities broker-dealer to participate in the
Transaction during the term of this engagement without our prior written consent. We reserve the right to retain other broker-dealers
to act as sub-agents on our behalf and to retain foreign representatives to act on our behalf for offers to non-United States persons
(as defined under the Securities Act of 1933). We are an independent contractor to you and do not assume the responsibilities of
a fiduciary to you or your shareholders in connection with the performance of our services.

 

This Agreement shall not give rise to any
commitment by us to act as a principal in a Transaction and we will have no authority to bind you. With your consent, we may retain
other advisors or consultants to act on our behalf in connection with a Transaction. An affiliate of JMP may elect to purchase
Securities, but any such decision and relationship is entirely independent of our agreement hereunder.

 

JMP Securities LLC

	600 Montgomery Street	tel	415.835.8900
	Suite 1100	fax	415.835.8920
	San Francisco, CA 94111	www.jmpsecurities.com

 

 

    	 

    	 

    

 

Navidea Biopharmaceuticals

September 10, 2013

Page 2 of 4

 

The term of our engagement
will begin on the date hereof and continue for six (6) months or until earlier terminated by the final closing of a Transaction
or our mutual written agreement. Our engagement may also be terminated by either party upon 30 days’ prior written notice.
Any early termination of our engagement by the Company will not affect your obligation to pay our fees or reimburse our expenses.

 

Except with respect
to the Transaction contemplated by this Agreement, for a period commencing one week prior to the closing and ending ninety (90)
days following the closing of the Transaction (the “Lock-Up Period”), the Company will not, and will cause each named
executive officer (as identified in the Company’s most recent Proxy Statement) and director of the Company to agree in writing
with us that he or she will not, directly or indirectly, (1) offer for sale, sell, pledge or otherwise dispose of (or enter into
any transaction or device which is designed to, or could be expected to, result in the disposition by any person at any time in
the future of) any shares of Company common stock or any securities convertible into or exchangeable for Company common stock,
or sell or grant options, rights or warrants with respect to any shares of Company common stock or securities convertible into
or exchangeable for Company common stock (other than the grant of options pursuant to option plans existing on the date hereof),
(2) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits
or risks of ownership of such shares of Company common stock, whether any such transaction described in clause (1) or (2) above
is to be settled by delivery of common stock or other securities, in cash or otherwise, in each case without the prior written
consent of us. The foregoing restriction shall not apply to (i) securities required to be issued pursuant to contractual obligations
of the Company in effect as of the date of this Agreement; or (ii) equity securities issued pursuant to employee benefit or purchase
plans in effect as of the date of this letter agreement or pursuant to bona fide employee benefit or purchase plans established
during the Lock-Up Period.

 

At the closing of a
Transaction with Crede Capital Group LLC or one or more of its affiliates (“Crede”) during the term of our engagement
and one month thereafter, a fee of three and one-third percent (3.33%) of the gross proceeds of such Transaction will be due to
us. At the closing of a Transaction with any investor(s) other than Crede during the term of our engagement and one month thereafter,
a fee of six percent (6.0%) of the gross proceeds of such Transaction will be due to us. Our fee will be paid immediately upon
closing and out of the proceeds of the Transaction and shall not be reduced by any obligation that the Company may have to any
other broker or finder.

 

In addition to the
fee payable to us under this Agreement, the Company agrees to reimburse us upon request for our out-of-pocket expenses incurred
in connection with our services under this Agreement (with supporting invoices or receipts), including the reasonable fees and
disbursements of our legal counsel. Without the written consent of the Company, such expenses, fees and disbursements shall not
exceed $100,000. You will reimburse us within thirty (30) days after receipt of an invoice from us. All expenses normally borne
by the Company for transactions of this type will be paid by the Company.

 

We and the Company
agree to the terms set forth in Exhibit A, which is incorporated by reference into this agreement and shall survive any termination
or expiration of our engagement. If an agreement for a sale of the Company is entered into and the obligations of the Company in
Exhibit A are not assumed, in a form and manner satisfactory to JMP, by operation of law or contract by the acquiring
entity, the Company agrees to arrange alternative means of providing for such obligations prior to consummation of such transaction,
including providing insurance or creating an escrow, in each case in an amount and upon terms and conditions satisfactory to JMP.

 

    	 

    	 

    

 

Navidea Biopharmaceuticals

September 10, 2013

Page 3  of 4

 

You agree that we have
the right to publicize our involvement in a Transaction and place “tombstones” at our expense describing our services
hereunder, but we agree not to use or disclose any confidential information concerning you for any purposes other than those contemplated
in the agreement. If we request, you will include a mutually acceptable reference to us in the press release or other public announcement
by you regarding a Transaction. The Company understands and agrees that, without JMP’s prior written consent, which shall
not be unreasonably withheld, JMP may not be quoted or referred to in any document, release, or communication prepared, issued,
or transmitted by the Company, including any entity controlled by, or under common control with, the Company and any director,
officer, employee or agent thereof, unless the Company is required to disclose such information.

 

All notices or communications
hereunder will be in writing and mailed or delivered to the parties at addresses set forth on the first page of this agreement
and to the attention of the signatories to this agreement. The representations, warranties and covenants of the Company set forth
herein will remain in full force and effect regardless of any investigation made by or on behalf of us, any potential investor
in a Transaction or any other entity or persons and will survive the closing of the Transaction. The provisions of this agreement
regarding fees, expenses and Exhibit A shall survive any termination or expiration of our engagement.

 

This agreement, including
Exhibit A, shall be governed by and construed in accordance with the internal laws of the State of New York without giving effect
to any principles of conflicts of law. Each of we and the Company (on its own behalf and, to the extent permitted by law, on behalf
of its shareholders) waives any right to trial by jury in any action, claim, suit or proceeding and consents to personal jurisdiction
and exclusive venue in the federal or state courts located in the city and county of New York, New York with respect to our engagement
under or actions in connection with this agreement.

 

This agreement, together
with Exhibit A hereto, contains the entire agreement between us concerning a Transaction and supersedes any prior understanding
or agreement. Any amendment or waiver of any right or obligation must be in writing signed by the party against whom it is sought
to be enforced. The rights and obligations you have or may have to us or any of our affiliates under any other agreement are separate
from your rights and obligations under this agreement and will not be affected by our performance or failure to perform hereunder.
The officer signing below is duly authorized to execute this agreement on behalf of the Company and upon execution; it shall be
binding against the Company and in full force and effect.

 

This agreement may
not be assigned by any party without the prior written consent of the parties. The benefits of this agreement and the attached
indemnification shall inure to the respective successors and assigns of the parties to and persons indemnified under this agreement
and their successors, assigns and representatives, and the obligations and liabilities assumed in this agreement and the attached
indemnification shall be binding upon each party’s respective successors and assigns.

 

[Remainder of the page
intentionally left blank.]

 

    	 

    	 

    

 

Navidea Biopharmaceuticals

September 10, 2013

Page 4  of 4

 

This agreement is effective
as of the date first set forth above. Please confirm that the foregoing correctly and completely sets forth our understanding by
signing and returning to us the enclosed duplicate of this agreement. We thank you for the opportunity to share in your business
endeavors and are looking forward to a successful and mutually beneficial relationship.

 

	 	Very truly yours,
	 	 
	 	JMP SECURITIES LLC
	 	 
	 	By: 	 /s/ Kent Ledbetter
	 	 	Kent Ledbetter
	 	 	Director of Investment Banking

 

Accepted and agreed as of the date first written above:

 

NAVIDEA
BIOPHARMACEUITCALS, INC. 

 

	By: 	/s/ Brent L. Larson	 
	 	Brent L. Larson
	 	Chief Financial Officer

 

    	 

    	 

    

 

EXHIBIT A

 

INDEMNIFICATION
AGREEMENT

 

The signatory to the attached Engagement
Agreement (“we,” “our,” “us” or the “Company”) hereby agrees to indemnify JMP Securities
LLC (“JMP”), its affiliates, and each of their respective members, officers, directors, agents, employees and controlling
persons (within the meaning of Section 20 of the Securities Exchange Act of 1934 and Section 15 of the Securities Act of 1933)
(each of the foregoing, including JMP, an “Indemnified Person”) and to hold each Indemnified Person harmless from and
against any and all losses, claims, damages, expenses (including reasonable fees, disbursements and other charges of counsel, all
of which shall be payable quarterly as they are incurred), whether joint or several (all of the foregoing, “Liabilities”),
to which any Indemnified Person may become liable or subject, directly or indirectly, based upon, relating to or arising out of
the engagement agreement to which this Indemnification Agreement is attached (the “Engagement Agreement”) or any Indemnified
Person’s role therein; provided, however, that we shall not be liable under this paragraph to the extent it
is finally judicially determined by a court of competent jurisdiction that such Liabilities resulted primarily from the willful
misconduct, gross negligence, or violation of applicable law of such Indemnified Person.

 

We also agree to reimburse each Indemnified
Person promptly upon request for all expenses (including reasonable fees, disbursements and other charges of counsel) as they are
incurred in connection with the investigation of, preparation for, defense of, or provision of evidence in, any action (including
actions brought by us or our equity holders or derivative actions brought by any person claiming through us or in our name), claim,
suit, arbitration, proceeding or investigation, whether formal or informal, directly or indirectly, relating to or arising out
of, the Engagement Agreement or any Indemnified Person’s role therein, whether or not pending or threatened and whether or
not any Indemnified Person is a party to such proceeding. Notwithstanding the foregoing, the relevant Indemnified Person shall
repay such reimbursements to the extent they are attributable to Liabilities finally judicially determined by a court of competent
jurisdiction to have resulted primarily from the willful misconduct, gross negligence or violation of applicable law of such Indemnified
Person.

 

We further agree that no Indemnified Person
shall have any liability (whether direct or indirect, in contract, tort or otherwise) to us or anyone claiming through us or in
our name or right, directly or indirectly, in connection with (i) advice or services rendered or to be rendered by any Indemnified
Person pursuant to the Engagement Agreement; (ii) the transactions contemplated by the Engagement Agreement or (iii) any Indemnified
Person’s actions or inactions in connection with any such advice, services or transactions except to the extent that it is
finally judicially determined by a court of competent jurisdiction that such Liabilities resulted primarily from the willful misconduct,
gross negligence or violation of applicable law of the relevant Indemnified Person. In no event will any Indemnified Person be
liable or obligated in any manner for any consequential, exemplary or punitive damages or lost profits arising out of the Engagement
Agreement or any services provided thereunder and the Company agrees not to seek or claim any such damages or lost profits in any
circumstances.

 

Promptly after JMP receives notice of the
commencement of any action or other proceeding in respect of which indemnification or reimbursement may be sought hereunder, JMP
will notify thereof; but the omission so to notify us shall not relieve us from any obligation hereunder unless, and only to the
extent that, such omission results in our forfeiture of substantive rights or defenses. If any such action or other proceeding
shall be brought against any Indemnified Person, we shall, upon written notice given reasonably promptly following your notice
to us of such action or proceeding, be entitled to assume the defense thereof at our expense with counsel chosen by us and reasonably
satisfactory to such Indemnified Person; provided, however, that any Indemnified Person may at its own expense retain
separate counsel to participate in such defense. Notwithstanding the foregoing, such Indemnified Person shall have the right to
employ separate counsel at our expense and to control its own defense of such action or proceeding if, in the reasonable opinion
of counsel to such Indemnified Person, (i) there are or may be legal defenses available to such Indemnified Person or to other
Indemnified Persons that are different from or additional to those available to us, or (ii) a conflict may arise between the positions
of the Indemnified Person and us in conducting the defense of any such action that would make such separate representation advisable;
provided, however, that in no event shall we be required to pay fees and expenses under this indemnity for more than
one firm of attorneys (in addition to local counsel) in any jurisdiction in any one legal action or group of related legal actions.

 

If for any reason the foregoing indemnification
and/or reimbursement is unavailable to any Indemnified Person or insufficient to hold it harmless, then we will contribute to the
amount paid or payable by such Indemnified Person as a result of such Liabilities in such proportion as is appropriate to reflect
the relative benefits to the Company on the one hand and JMP on the other hand in connection with the transaction to which such
indemnification or reimbursement relates or if such allocation is not available, in such proportion as is appropriate to reflect
not only the relative benefits, but also the relative fault of the parties as well as any other relevant equitable considerations,
provided, however, that in no event shall the aggregate amount to be contributed by all Indemnified Persons exceed the fees actually
received by JMP under the Engagement Agreement.

 

We will not, without the prior written
consent of JMP, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding
in respect of which indemnification could be sought hereunder (whether or not any Indemnified Person is a party thereto) unless
such settlement, compromise or consent includes a full and unconditional release reasonably satisfactory to JMP of JMP and each
other Indemnified Person from all liability arising or that may arise out of such claim, action or proceeding and the parties agree
that the terms of such settlement, compromise and consent shall remain confidential.

 

The rights accorded to Indemnified Persons
hereunder shall be in addition to any rights that any Indemnified Person may have at common law, by separate agreement or otherwise.
If any provision hereof shall be determined to be invalid or unenforceable in any respect, such determination shall not affect
such provision in any other respect or any other provision of this agreement, which shall remain in full force and effect. Each
Indemnified Person is an intended beneficiary hereunder. The foregoing Indemnification Agreement shall remain in effect indefinitely
notwithstanding any expiration or termination of the Engagement Agreement.

  

 

    	A-1EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT (the “Agreement”)
is made effective as of October 1, 2013 (the “Effective Date”), by and among Mandalay Digital Group,
Inc., a Delaware corporation (the “Employer”), and Peter A. Adderton (the “Executive”).
In consideration of the mutual covenants contained in this Agreement, the Employer and the Executive agree as follows:

 

1.          Employment.
The Employer agrees to employ the Executive, and the Executive agrees to be employed by the Employer on the terms and conditions
set forth in this Agreement.

 

2.          Capacity.
The Executive currently serves on the Board of Directors of the Employer (the “Board of Directors”) and
shall serve the Employer as Chief Executive Officer. Subject to the discretion of the Nominating Committee of the Board of Directors,
Executive shall serve as a member of the Board of Directors without additional compensation, subject to stockholder approval at
the Employer’s annual meeting of stockholders. At the end of the Term (as defined below), Executive shall offer to resign
from the Boards of Directors and any similar body at a subsidiary of the Employer. As Chief Executive Officer, the Executive shall
be responsible for the general supervision, management and control of the Employer’s business, subject to the direction of
the Board of Directors. The Executive shall report directly to the Board of Directors. It is agreed that the Board has previously
determined that any CFO hired will report directly to, and will actively interact with, the Board of Directors and that such arrangement
is acceptable to the Executive and does not constitute “Good Reason” hereunder. At the reasonable request of the Board
of Directors, the Executive shall provide services to subsidiaries and affiliates of the Employer, without additional compensation
becoming payable. At any time after the first anniversary of the Effective Date during the Term, at the request of the Board of
Directors, the Executive’s capacity shall change to being the Chief Innovation Officer rather than the Chief Executive Officer
(a “Change in Capacity”). As Chief Innovation Officer, the Executive shall be responsible for assisting
the Chief Executive Officer in developing, setting, monitoring and implementing product development efforts, strategic initiatives,
marketing approaches, joint ventures, acquisitions and other related matters, subject to the direction of the Board of Directors
and the Chief Executive Officer. As Chief Innovation Officer, the Executive shall report directly to the Chief Executive Officer.
After a Change in Capacity, Executive shall (in addition to his duties as Chief Innovation Officer) continue to support the Employer
in finding and transitioning any new Chief Executive Officer that the Employer may retain without additional compensation becoming
payable for such assistance. Executive represents he is and at all times during the Term will be legally present and entitled to
work in the United States.

 

3.          Term.
Subject to the provisions of Section 6, the term of employment pursuant to this Agreement shall be two (2) years, i.e., twenty-four
(24) calendar months, from the Effective Date (the “Term”).

 

4.          Compensation
and Benefits. The regular compensation and benefits payable to the Executive under this Agreement shall be as follows:

 

    	 

    	 

    

 

(a)          Salary.
For all services rendered by the Executive under this Agreement, the Employer shall pay the Executive an annual salary (the “Salary”)
at the annual rate of Five Hundred Thousand Dollars ($500,000). The Executive’s Salary shall be payable in periodic installments
in accordance with the Employer’s usual practice for its employees, but in no event less than monthly over the year in which
the Salary is earned.

 

(b)          Bonuses.

 

(i)          Signing
Bonus. The Executive shall be entitled to a bonus of Five Hundred Thousand Dollars ($500,000.00) payable (A) 50% within
five (5) days of signing this Agreement and (B) the remaining 50% as follows: $125,000.00 on December 31, 2013 and $125,000.00
on March 31, 2014.

 

(ii)         Annual Bonus. While he
is Chief Executive Officer, the Executive shall be entitled to be paid an annual incentive bonus in cash in an amount of up to
150% of the Executive’s Salary based upon satisfaction of performance-related milestones, as specified on Schedule A subsections
(1) or (2) as applicable. While he is Chief Innovation Officer, the Executive shall be entitled to be paid an annual incentive
bonus in cash in an amount of up to 100% of the Executive’s Salary based upon satisfaction of performance-related milestones,
as specified on Schedule A subsection (3). All bonus amounts under this subsection shall (a) be paid within thirty (30) days after
the revenue and EBITDA criteria are determined for the applicable yearly period in the manner described in Schedule A, and (b)
be conditioned on Executive being employed throughout the entire yearly period with respect to which the bonus is determined.

 

(c)          Regular
Benefits. 

 

(i)          The
Executive shall also be entitled to participate in any qualified retirement plans, deferred compensation plans, stock option and
incentive plans, stock purchase plans, group and executive medical insurance plans (i.e., coverage for the Executive and family),
life insurance plans, disability income plans, retirement plans, vacation plans, expense reimbursement plans and other benefit
plans which the Employer may from time to time have in effect for any, all or most of its senior executives (collectively “Employer
Benefit Plans”). Such participation shall be subject to the terms of applicable plan documents, generally applicable
policies of the Employer, applicable law and the discretion of the Board of Directors, the Compensation Committee or any administrative
or other committee provided for in or contemplated by any such plan. Nothing contained in this Agreement shall be construed to
create any obligation on the part of the Employer to establish any such plans or to maintain the effectiveness of any such plans
which may be in effect from time to time.

 

(ii)         Notwithstanding
the Executive’s right to participate in Employer Benefit Plans, the Executive may elect to purchase separate medical insurance
and related benefits for himself and his family, and the Employer shall reimburse the Executive for all of the Executive’s
out-of-pocket costs in connection with obtaining and maintaining such insurance and related benefits but not for any incremental
cost to the Employer over and above what it would cost the Employer to provide Executive and his family medical insuance and related
benefits under the Employer’s standard insurance plans. 

 

    	 

    	 

    

 

(d)          Reimbursement
of Business Expenses. The Employer shall reimburse the Executive for all reasonable expenses incurred by the Executive
in performing services during the Term, in accordance with the Employer’s policies and procedures for its senior executive
officers, as in effect from time to time, including, but not limited to, business class air travel (or, if unavailable, first class),
meals and entertainment, fuel costs for transportation, wireless mobile communications, and personal computer equipment.

 

(e)          Stock
Option Grant. On the Effective Date, the Employer shall grant the Executive 500,000 options to purchase common stock of
the Employer at an exercise price equal to the closing price of the Employer’s common stock on the Nasdaq Capital Market
on the Effective Date (or if the Effective Date is not a trading day, on the next trading day after the Effective Date) under a
shareholder-approved equity incentive plan, subject to the terms and conditions specified in the Employer’s standard stock
option agreement, which shall vest as follows: (i) 250,000 options shall vest on the one year anniversary of the Effective Date;
(ii) 250,000 options shall vest on the two year anniversary of the Effective Date; and (iii) all unvested options shall vest immediately
upon the sale of all or substantially all of the assets of the Employer, upon the merger or reorganization of the Employer following
which the equityholders of the Employer immediately prior to the consummation of such merger or reorganization collectively own
less than 50% of the voting power of the resulting entity, or upon the sale of equity securities of the Employer representing 50%
or more of the voting power of the Employer or 50% or more of the economic interest in the Employer in a single transaction or
in a series of related transactions (i.e., a “Change of Control”). All shares shall be subject to a one
(1) year lock-up following the exercise of such options. The Employer has received informal guidance from Nasdaq that no shareholder
approval is required for the option grant contemplated hereby and to make a related change to the annual per person cap under the
amended and restated 2011 equity incentive plan; provided, however, the Employer (acting through the Compensation Committee) reserves
the right to seek formal guidance within forty-five days of the Effective Date as to such matters, and if Nasdaq indicates that
shareholder approval is in fact required, then the Executive and the Employer agree to take all reasonable actions to restructure
the grant (including, if necessary, subjecting it to shareholder approval as a condition to the option being exercisable, with
the Employer using best efforts to obtain such shareholder approval) in order to fully comply with Nasdaq shareholder approval
requirements.

 

(f)          Exclusivity
of Salary and Benefits. The Executive shall not be entitled to any payments or benefits other than those provided under
this Agreement.

 

5.          Extent
of Service. During the Executive’s employment under this Agreement, the Executive shall, subject to the direction
and supervision of the Board of Directors (or the Chief Executive Officer, if and when the Executive shall be the Chief Innovation
Officer), devote the Executive’s full business time, best efforts and business judgment, skill and knowledge to the advancement
of the Employer’s interests and to the discharge of the Executive’s duties and responsibilities under this Agreement.
The Executive shall not engage in any other business activity, except as may be approved by the Board of Directors; provided, however,
that nothing in this Agreement shall be construed as preventing the Executive from:

 

    	 

    	 

    

 

(a)          investing
the Executive’s personal assets in any non-competitive business enterprise, company or other entity in such form or manner
as shall not require any material personal time commitment on the Executive’s part in connection with the operations or affairs
of such other enterprise, company or other entity in which such investments are made;

 

(b)          engaging
in religious, charitable or other community or non-profit activities that do not impair the Executive’s ability to fulfill
the Executive’s duties and responsibilities under this Agreement; or

 

(c)          serving
as an executive officer of Boost Tel Pty. Ltd., a company organized under the laws of Australia, provided that his personal services
in such capacity do not require any material time commitment on the Executive’s part in connection with the operation or
affairs of such companies and, in any event, such role shall not impair the Executive’s ability to fulfill his duties and
responsibilities under this Agreement.

 

6.          Termination.
Notwithstanding the provisions of Section 3, the Executive’s employment under this Agreement shall terminate under the following
circumstances set forth in this Section 6. For purposes of this Agreement, the date of the Executive’s termination (the “Termination
Date”) shall mean the date of the Executive’s “separation from service” as such term is defined
under Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”).

 

(a)          Termination
by the Employer for Cause. The Executive’s employment under this Agreement may be terminated for Cause without further
liability on the part of the Employer effective immediately upon approval of the Board of Directors and written notice to the Executive.
Only the following shall constitute “Cause” for such termination:

 

(i)          any
act committed by the Executive against the Employer or any of its affiliates which involves fraud, willful misconduct, gross negligence
or insubordination; or

 

(ii)         the commission by the Executive of,
or indictment for (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, dishonesty or fraud.

 

(b)          Termination
by the Employer Without Cause. Subject to the payment of Termination Benefits pursuant to Section 7(b), the Executive’s
employment under this Agreement may be terminated by the Employer without Cause upon not less than fifteen (15) days’ prior
written notice to the Executive.

 

(c)          Death.
The Executive’s employment with the Employer shall terminate automatically upon his death.

 

    	 

    	 

    

 

(d)          Disability.
If the Executive shall become Disabled so as to be unable to perform the essential functions of the Executive’s then existing
position or positions under this Agreement with or without reasonable accommodation, the Board of Directors may remove the Executive
from any responsibilities and/or reassign the Executive to another position with the Employer for the remainder of the Term or
during the period of such Disability. Notwithstanding any such removal or reassignment, the Executive shall continue to receive
the Executive’s full Salary (less any disability pay or sick pay benefits to which the Executive may be entitled under the
Employer’s policies) and benefits under Section 4 of this Agreement (except to the extent that the Executive may be ineligible
for one or more such benefits under applicable plan terms) for a period of time equal to twelve (12) months payable at the same
time as such amounts would otherwise have been paid to the Executive had he continued in his current capacity. If the Executive
is unable to perform substantial services of any kind for the Employer during this period, such period shall be considered a paid
leave of absence and the Executive shall have the contractual right to return to employment at any time during such period. If
the Executive’s Disability continues beyond such twelve (12) month period, the Executive’s employment may be terminated
by the Employer by reason of Disability at any time thereafter. For purposes hereof, the term “Disabled”
or “Disability” shall mean a written determination that the Executive, as certified by at least two (2)
duly licensed and qualified physicians, one (1) approved by the Board of Directors of the Employer and one (1) physician approved
by the Executive (the “Examining Physicians”), or, in the event of the Executive’s total physical
or mental disability, the Executive’s legal representative, that the Executive suffers from a physical or mental impairment
that renders the Executive unable to perform the Executive’s regular personal duties under this Agreement and that such impairment
can reasonably be expected to continue for a period of six (6) consecutive months or for shorter periods aggregating one hundred
eighty (180) days in any twelve (12) month period; provided, however, that the Executive’s primary care physician may not
serve as one of the Examining Physicians without the consent of the Employer and the Executive (or the Executive’s legal
representation). The Executive shall cooperate with any reasonable request of a physician to submit to a physical examination for
purposes of such certification. Nothing in this Section 6(d) shall be construed to waive the Executive’s rights, if any,
under existing law including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. §2601 et seq. and the
Americans with Disabilities Act, 42 U.S.C. §12101 et seq.

 

(e)          Termination
by the Executive for Good Reason. Subject to the payment of Termination Benefits pursuant to Section 7(b), the Executive’s
employment under this Agreement may be terminated by the Executive for Good Reason. For purposes of this Agreement, “Good
Reason” shall be present where Executive gives notice to the Board of Directors of his voluntary resignation within thirty
(30) days after the occurrence of any of the following, without Executive’s written consent: (i) the failure of the Employer
to pay or cause to be paid Executive’s Salary or Annual Bonus, when due under the terms and conditions hereunder hereunder,
subject to a fifteen (15) day cure period by the Employer following notice by the Executive; or (ii) material diminution in Executive’s
position, duties, authority or responsibility, without Cause, subject to a thirty (30) day cure period by the Employer following
notice by the Executive (except that a Change in Capacity is not, without limitation, such a diminution).

 

7.          Compensation
Upon Termination.

 

(a)          Termination
Generally. If the Executive’s employment with the Employer is terminated for any reason during or upon expiration
of the Term, the Employer shall pay or provide to the Executive (or to his authorized representative or estate) (i) any earned
but unpaid Salary payable on the Termination Date, (ii) accrued bonuses for a previously completed yearly measurement period (for
avoidance of doubt, no pro-rata bonus is payable under this clause, only a bonus for a previously completed yearly measurement
period) earned but not yet paid, payable at the same time such amounts would otherwise have been paid to the Executive, (iii) any
unpaid expense reimbursements, payable in accordance with the Employer’s reimbursement policies, (iv) any accrued but unused
vacation, payable on the Termination Date, and (v) any vested benefits the Executive may have under any of the Employer Benefit
Plans, payable as specified in the applicable plan documents (collectively, the “Accrued Compensation”).

 

    	 

    	 

    

 

(b)          Termination
by the Employer Without Cause or by the Executive for Good Reason.
In the event of termination of the Executive’s employment with the Employer pursuant to Section 6(b) or 6(e) above prior
to the expiration of the Term, and subject to the Executive’s execution and delivery of a release of any and all
legal claims in a form satisfactory to the Employer within forty-five (45) days of the Termination Date (the “Release
Period”), the Employer shall provide to the Executive, in addition to the Accrued Compensation, the following termination
benefits (“Termination Benefits”) effective as of the final day of the Release Period:

 

(i)          continuation
of the Executive’s Salary at the rate and in accordance with the Employer’s payroll practices then in effect pursuant
to Section 4(a); and

 

(ii)         continuation of any executive health
and group health plan benefits to the extent authorized by and consistent with 29 U.S.C. § 1161 et seq. (commonly known as
“COBRA”), subject to payment of premiums by the Employer to the extent that the Employer was covering such premiums
as of the Termination Date (if permitted by law without violation of applicable discrimination rules, or, if not, the equivalent
after-tax value payable as additional severance at the same time such premiums are otherwise payable); and

 

(iii)        a
pro-rata annual bonus through the Termination Date, as reasonably determined by the Compensation Committee applying the applicable
standards in Schedule A; and

 

(iv)        acceleration
of vesting of the options granted under this Agreement on a pro-rata basis as if the vesting schedule had been monthly rather than
annual, advanced to the next month.

 

The Termination Benefits set forth in subsections 7(b)(i)
and (ii) and above shall continue effective for the remainder of the Term (the “Termination Benefits Period”);
provided, however, that in the event that the Executive commences any employment during the Termination Benefits Period, the benefits
provided under Section 7(b)(ii) shall cease effective as of the date Executive qualifies for group health plan benefits in his
new employment. The Employer’s liability for Salary continuation pursuant to Section 7(b)(i) shall not be reduced by the
amount of any severance pay paid to the Executive pursuant to any severance pay plan or stay bonus plan of the Employer. Notwithstanding
the foregoing, nothing in this Section 7(b) shall be construed to affect the Executive’s right to receive COBRA continuation
entirely at the Executive’s own cost to the extent that the Executive may continue to be entitled to COBRA continuation
after Employer-paid premiums cease. The Executive shall be obligated to give prompt notice of the date of commencement of any
employment during the Termination Benefits Period and shall respond promptly to any reasonable inquiries concerning any employment
in which the Executive engages during the Termination Benefits Period.

 

    	 

    	 

    

 

The Employer acknowledges and agrees that under certain circumstances
involving the termination of the Executive’s employment and/or a Change of Control transaction involving the Employer, the
Executive shall be entitled to accelerated vesting on his options to purchase shares of capital stock of the Employer, all to the
extent provided in that certain Stock Option Agreement referred to in Section 4(e) hereof.

 

Any Section 409A payments which are subject to execution of
a waiver and release which may be executed and/or revoked in a calendar year following the calendar year in which the payment event
(such as termination of employment) occurs shall commence payment only in the calendar year in which the Release Period ends as
necessary to comply with Section 409A.

 

(c)          Termination
by Reason of Cause, Death, Disability, Voluntary Termination or Expiration of Term. If the Executive’s employment
is terminated for any reason other than by the Employer without Cause under Section 6(b) or by the
Executive for Good Reason under Section 6(e), including by reason of the Employer’s election not to extend the Term,
the Employer shall have no further obligation to the Executive other than payment of his Accrued Compensation.

 

8.            Confidential
Information, Nonsolicitation and Cooperation.

 

(a)          Confidential
Information. As used in this Agreement, “Confidential Information” means proprietary information
of the Employer which is of value to the Employer in the course of conducting its business and the disclosure of which could result
in a competitive or other disadvantage to the Employer. Confidential Information includes, without limitation, financial information,
reports, and forecasts; inventions, improvements and other intellectual property; trade secrets; know-how; designs, processes or
formulae; software; market or sales information or plans; customer lists; and business plans, prospects and opportunities (such
as possible acquisitions or dispositions of businesses or facilities) which have been discussed or considered by the management
of the Employer. Confidential Information includes information developed by the Executive in the course of the Executive’s
employment by the Employer, as well as other information to which the Executive may have access in connection with the Executive’s
employment. Confidential Information also includes the confidential information of others with which the Employer has a business
relationship. Notwithstanding the foregoing, Confidential Information does not include (i) information in the public domain, unless
due to breach of the Executive’s duties under Section 8(b), or (ii) information obtained in good faith by the Executive from
a third party who was lawfully in possession of such information and not subject to an obligation of confidentiality owed to the
Employer.

 

(b)          Duty
of Confidentiality. The Executive understands and agrees that the Executive’s employment creates a relationship of
confidence and trust between the Executive and the Employer with respect to all Confidential Information. At all times, both during
the Executive’s employment with the Employer and after termination, the Executive will keep in confidence and trust all such
Confidential Information, and will not use or disclose any such Confidential Information without the written consent of the Employer,
except (i) as may be necessary in the ordinary course of performing the Executive’s duties to the Employer or (ii) as may
be required in response to a valid order by a court or other governmental body or as otherwise required by law (provided that if
the Executive is so required to disclose the Confidential Information, the Executive shall (i) immediately notify the Employer
of such required disclosure sufficiently in advance of the intended disclosure to permit the Employer to seek a protective order
or take other appropriate action, (ii) cooperate in any effort by the Employer to obtain a protective order or other reasonable
assurance that confidential treatment will be afforded the Confidential Information).

 

    	 

    	 

    

 

(c)          Documents,
Records, etc. All documents, records, data, apparatus, equipment and other physical property, whether or not pertaining
to Confidential Information, which are furnished to the Executive by the Employer or are produced by the Executive in connection
with the Executive’s employment will be and remain the sole property of the Employer. The Executive will return to the Employer
all such materials and property as and when requested by the Employer. In any event, the Executive will return all such materials
and property immediately upon termination of the Executive’s employment for any reason. The Executive will not retain with
the Executive any such material or property or any copies thereof after such termination.

 

(d)          Nonsolicitation.
During the Term and for one (1) year thereafter, the Executive (i) will refrain from directly or indirectly employing, attempting
to employ, recruiting or otherwise soliciting, inducing or influencing any person to leave employment with the Employer (other
than subordinate employees whose employment was terminated in the course of the Executive’s employment with the Employer);
and (ii) will refrain from soliciting or encouraging any customer or supplier to terminate or otherwise modify adversely its business
relationship with the Employer. The Executive understands that the restrictions set forth in this Section 8(d) are intended to
protect the Employer’s interest in its Confidential Information and established employee, customer and supplier relationships
and goodwill, and agrees that such restrictions are reasonable and appropriate for this purpose.

 

(e)          Third-Party
Agreements and Rights. The Executive hereby confirms that the Executive is not bound by the terms of any agreement with
any previous employer or other party which restricts in any way the Executive’s use or disclosure of information or the Executive’s
engagement in any business. The Executive represents to the Employer that the Executive’s execution of this Agreement, the
Executive’s employment with the Employer and the performance of the Executive’s proposed duties for the Employer will
not violate any obligations the Executive may have to any such previous employer or other party. In the Executive’s work
for the Employer, the Executive will not disclose or make use of any information in violation of any agreements with or rights
of any such previous employer or other party, and the Executive will not bring to the premises of the Employer any copies or other
tangible embodiments of non-public information belonging to or obtained from any such previous employment or other party.

 

    	 

    	 

    

 

(f)          
Litigation and Regulatory Cooperation. During and after the Executive’s employment, the Executive shall cooperate
reasonably with requests from the Employer, or the Employer’s legal counsel, in the defense or prosecution of any claims
or actions now in existence or which may be brought in the future against or on behalf of the Employer which relate to events or
occurrences that transpired while the Executive was employed by the Employer. The Executive’s cooperation in connection with
such claims or actions shall include, but not be limited to, being available to meet with counsel to prepare for discovery or trial
and to act as a witness on behalf of the Employer at mutually convenient times. During and after the Executive’s employment,
the Executive also shall cooperate fully with the Employer in connection with any investigation or review of any federal, state
or local regulatory authority as any such investigation or review relates to events or occurrences that transpired while the Executive
was employed by the Employer. The Employer shall reimburse the Executive for any reasonable out-of-pocket expenses incurred in
connection with the Executive’s performance of obligations pursuant to this Section 8(f), and if the Executive spends more
than ten (10) hours in any calendar month in performance of these obligations, the Employer shall pay the Executive $500 per hour
for each part of an hour over ten (10) hours in such calendar month.

 

(g)          Intellectual
Property. Except as provided under Section 2870 of the California Labor Code (a copy of which is attached as Schedule B),
the Employer shall be the sole owner of all the products and proceeds of Executive’s services hereunder and under the Prior
Agreement, including, without limitation, all materials, ideas, concepts, formats, suggestions, developments, and other intellectual
properties that Executive may acquire, obtain, develop or create in connection with his services hereunder and during the Term
and under the Prior Agreement, free and clear of any claims by Executive (or anyone claiming under Executive) of any kind or character
whatsoever (other than Executive’s rights and benefits hereunder). Executive shall, at the request of the Employer, execute
such assignments, certificates or other instruments as the Employer may from time to time deem necessary or desirable to evidence,
establish, maintain, perfect, protect, enforce or defend the Employer’s right, title and interest in and to any such products
and proceeds of Executive’s services hereunder.

 

(h)          Injunction.
The Executive agrees that it would be difficult to measure any damages caused to the Employer which might result from any breach
by the Executive of the promises set forth in this Section 8, and that in any event money damages may be an inadequate remedy for
any such breach. Accordingly, subject to Section 9 of this Agreement, the Executive agrees that if the Executive breaches, or proposes
to breach, any portion of this Agreement, the Employer shall be entitled, in addition to all other remedies that it may have, to
an injunction or other appropriate equitable relief to restrain any such breach without showing or proving any actual damage to
the Employer and without the need to post a bond or other security.

 

    	 

    	 

    

 

9.          Arbitration
of Disputes. In the event of any dispute or controversy arising out of, or relating to, this Agreement, the parties hereto
agree to submit such dispute or controversy to binding arbitration pursuant to either the JAMS Streamlined (for claims under $250,000.00)
or the JAMS Comprehensive (for claims over $250,000.00) Arbitration Rules and Procedures, except as modified herein, including
the Optional Appeal Procedure. A sole neutral arbitrator shall be selected from the list (the “List”)
of arbitrators supplied by J.A.M.S. (“JAMS”) Los Angeles County, California office, or any successor
entity, or if it no longer exists, from a List supplied by the ADR Services, Inc., in Los Angeles, California (“ADR”)
following written request by any party hereto. If the parties hereto after notification of the other party(-ies) to such dispute
cannot agree upon an arbitrator within thirty (30) days following receipt of the List by all parties to such arbitration, then
either party may request, in writing, that JAMS or ADR, as appropriate, appoint an arbitrator within ten (10) days following receipt
of such request (the “Arbitrator”). The arbitration shall take place in Los Angeles County, California,
at a place and time mutually agreeable to the parties or, if no such agreement is reached within ten (10) days following notice
from the Arbitrator, at a place and time determined by the Arbitrator. Such arbitration shall be conducted in accordance with the
Streamlined Arbitration Rules and Procedures of JAMS then in effect, and Section 1280 et seq. of the California Code of Civil Procedure,
or if applicable, the Commercial Arbitration Rules of ADR then in effect. The preceding choice of venue is intended by the parties
to be mandatory and not permissive in nature, thereby precluding the possibility of litigation between the parties with respect
to or arising out of this Agreement in any jurisdiction other than that specified in this Section. Each party hereby waives any
right it may have to assert the doctrine of forum non conveniens or similar doctrine or to object to venue with respect to any
proceeding brought in accordance with this Section, and stipulates that the Arbitrator shall have in personam jurisdiction and
venue over each of them for the purpose of litigating any dispute, controversy, or proceeding arising out of or related to this
Agreement. Each party hereby authorizes and accepts service of process sufficient for personal jurisdiction in any action against
it as contemplated by this Section by registered or certified mail, return receipt requested, postage prepaid, to its address for
the giving of notices as set forth in this Agreement. The decision of the Arbitrator shall be final and binding on all the parties
to the arbitration, shall be non-appealable and may be enforced by a court of competent jurisdiction. The prevailing party shall
be entitled to recover from the non-prevailing party reasonable attorney’s fees, as well as its costs and expenses. The Arbitrator
may grant any remedy appropriate including, without limitation, injunctive relief or specific performance. Notwithstanding any
of the foregoing, the Employer may seek a temporary restraining order or a preliminary injunction as contemplated in Section 8(h)
herein.

 

10.         Integration. This Agreement constitutes the
entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements between the
parties with respect to any related subject matter, including that certain Employment Agreement between Employer and Executive
dated as of December 28, 2011 (the “Prior Agreement”), which expired on December
28, 2012; provided, however, that this Agreement does not affect any rights Executive has under the Prior Agreement to special
bonuses based on enterprise value to the extent set forth in Section 4(f) of the Prior Agreement or to any and all awards or grants
of stock, warrants or options that have been previously granted to Executive, including, without limitation, the vesting, value
and transferability of them, including, without limitation, those set forth in Section 4(e) of the Prior Agreement, the Restricted
Stock Agreement between Employer and Executive dated as of December 28, 2011 (the “Restricted Stock Agreement”)
or in any other agreement between Employer and Executive; provided, however the parties agree that no bonus under Section 4(b)(ii)
of the Prior Agreement became, was, is or will be due or payable to Executive and that Executive waives and releases all claims
thereto and will not bring any claims therefor.

 

11.         Assignment; Successors and Assigns, etc. Neither
the Employer nor the Executive may make any assignment of this Agreement or any interest herein, by operation of law or otherwise,
without the prior written consent of the other party; but the Employer may assign its rights under this Agreement without the consent
of the Executive, in the event that the Employer shall effect a reorganization, consolidate with or merge into any other corporation,
partnership, organization or other entity, or transfer all or substantially all of its properties or assets to any other corporation,
partnership, organization or other entity, in which event the Employer will obtain a written confirmation of the assumption of
the Employer’s obligation hereunder for the benefit of the Executive. This Agreement shall inure to the benefit of and be
binding upon the Employer and the Executive, their respective successors, executors, administrators, heirs and permitted assigns.

 

    	 

    	 

    

 

12.         Enforceability. If any portion or provision
of this Agreement (including, without limitation, any portion or provision of any section of this Agreement) shall to any extent
be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application
of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not
be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted
by law.

 

13.         Waiver. No waiver of any provision hereof
shall be effective unless made in writing and signed by the waiving party. The failure of any party to require the performance
of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any
subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.

 

14.         Notices. Any notices, requests, demands and
other communications provided for by this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally
recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to the Executive
at the Executive’s last residential address the Executive has filed in writing with the Employer or, in the case of the Employer,
at its main offices, attention of the Chairman of the Board, and shall be effective on the date of delivery in person or by courier
or three (3) days after the date mailed.

 

15.         Third Party Beneficiary; Amendment. The Executive
and the Employer acknowledge and agree that no third party shall have any rights or benefits under this Agreement, except for the
parties specifically named as released parties in Section 21. This Agreement may be amended or modified only by a written instrument
signed by the Executive and the Employer.

 

16.         Governing Law. This contract has been entered
into in the State of California and shall be construed under and be governed in all respects by the laws of the State of California,
without giving effect to the conflict of laws principles of such state; provided, however, that Section 19 shall be governed by
the laws of the State of Delaware.

 

17.         Counterparts. This Agreement may be executed
in any number of original, facsimile or other electronic counterparts, each of which when so executed and delivered shall be taken
to be an original; but such counterparts shall together constitute one and the same document.

 

18.         No Prior Agreements. The Executive hereby
represents and warrants to the Employer and that the execution of this Agreement by the Executive, the Executive’s employment
by the Employer, and the performance of the Executive’s duties hereunder will not violate or constitute a breach of any agreement,
including any non-competition agreement, invention or confidentiality agreement, with a former employer, client or any other person
or entity. Further, the Executive agrees to indemnify the Employer for any loss, including, but not limited to, reasonable attorneys’
fees and expenses, that the Employer may incur based upon or arising out of the Executive’s breach of this Section.

    	 

    	 

    

 

19.         Indemnification. The Employer shall indemnify
the Executive against and hold the Executive harmless from any costs, liabilities, losses and exposures for the Executive’s
services as an employee, officer and director of the Employer (or any successor in interest thereof), whether before or after the
Effective Date, to the maximum extent permitted under the Delaware General Corporate Law. If the Executive is made a party to any
threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than
an action by the Employer against the Executive), by reason of the fact that the Executive is or was performing services to the
Employer under this Agreement or while acting as an executive officer of the Employer, the Employer shall indemnify the Executive
against all expenses (including reasonable attorneys’ fees), judgments, fines and amounts paid in settlement, as actually
and reasonably incurred by the Executive in connection therewith, to the maximum extent permitted under the Delaware General Corporation
Law. If the Executive is made a party to any third-party action, complaint, suit or proceeding, the Executive shall given prompt
notice thereof to the Employer, and the Employer shall have the right to assume and control the defense of such action, complaint,
suit or proceeding; provided, however, that if legal counsel selected by the Employer shall have a conflict of interest that prevents
such counsel from representing the Executive, the Executive may engage separate counsel and the Employer shall reimburse all reasonable
attorneys’ fees and reasonable expenses of such separate counsel. Notwithstanding the foregoing, the Employer shall not have,
and the Executive acknowledges and agrees that the Employer does not have, any obligation to indemnify the Executive under this
Section or under its certificate of incorporation or bylaws, with respect to (a) any breach of representation, warranty or covenant
committed by the Executive under this Agreement, or (b) any action or inaction by the Executive where the Executive failed to act
in good faith and in a manner the Executive reasonably believed to be in, or not opposed to, the best interests of the Employer,
or with respect to any criminal action or proceeding, the Executive had reasonable cause to believe that his conduct was unlawful.

 

20.         Directors’ and Officers’ Insurance.
As soon as reasonably practicable following the Effective Date, the Employer shall use commercially reasonable efforts to obtain
(if it does not already have) directors’ and officers’ insurance from a reputable insurance company with such coverage
amounts and policy terms as is customary for public companies with market valuations similar to the Employer, as determined by
the Employer in its sole discretion.

 

21.         [Omitted Intentionally]. 

 

22.         Withholding
Obligations. The Employer, or any other entity making a payment, may withhold and make such deductions from any amounts
payable under this Agreement such federal, state and local taxes as may be required to be withheld or deducted from time to time
pursuant to any applicable law, governmental regulation and/or order.

 

23.         Section
954 of the Dodd Frank Act. This Agreement and all other Compensation of Executive are intended to comply with the “clawback
obligations” of Section 954 of the Dodd Frank Act (including the related regulations, “Section 954”).
If the Employer’s financial statements must be restated, to the extent and only to the extent required by Section 954 (if
applicable), the Employer shall be entitled to recover from Executive, and Executive agrees to promptly repay, any incentive-based
compensation which would not have been earned under the restated financial statements.

 

    	 

    	 

    

 

24.         Section 409A Compliance. Unless otherwise
expressly provided, any payment of compensation by the Employer to the Executive, whether pursuant to this Agreement or otherwise,
shall be made no later than the fifteenth (15th) day of the third (3rd) month (i.e., 21⁄2 months) after the later of the end
of the calendar year or the Employer’s fiscal year in which the Executive’s right to such payment vests (i.e., is not
subject to a “substantial risk of forfeiture” for purposes of Section 409A). Each payment and each installment of any
bonus or severance payments provided for under this Agreement shall be treated as a separate payment for purposes of application
of Section 409A. To the extent any amounts payable by the Employer to the Executive constitute “nonqualified deferred compensation”
(within the meaning of Section 409A) such payments are intended to comply with the requirements of Section 409A, and shall be interpreted
in accordance therewith. Neither party individually or in combination may accelerate, offset or assign any such deferred payment,
except in compliance with Section 409A. No amount shall be paid prior to the earliest date on which it is permitted to be paid
under Section 409A and the Executive shall have no discretion with respect to the timing of payments except as permitted under
Section 409A. In the event that the Executive is determined to be a “key employee” (as defined and determined under
Section 409A) of the Employer at a time when its stock is deemed to be publicly traded on an established securities market, payments
determined to be “nonqualified deferred compensation” payable upon separation from service shall be made no earlier
than (a) the first (1st) day of the seventh (7th) complete calendar month following such termination of employment, or (b) the
Executive’s death, consistent with the provisions of Section 409A. Any payment delayed by reason of the prior sentence shall
be paid out in a single lump sum at the end of such required delay period in order to catch up to the original payment schedule.
All expense reimbursement or in-kind benefits subject to Section 409A provided under this Agreement or, unless otherwise specified
in writing, under any Employer program or policy, shall be subject to the following rules: (i) the amount of expenses eligible
for reimbursement or in-kind benefits provided during one calendar year may not affect the benefits provided during any other year;
(ii) reimbursements shall be paid no later than the end of the calendar year following the year in which the Executive incurs such
expenses, and the Executive shall take all actions necessary to claim all such reimbursements on a timely basis to permit the Employer
to make all such reimbursement payments prior to the end of said period, and (iii) the right to reimbursement or in-kind benefits
shall not be subject to liquidation or exchange for another benefit. The Executive shall be responsible for the payment of all
taxes applicable to payments or benefits received from the Employer. It is the intent of the Employer that the provisions of this
Agreement and all other plans and programs sponsored by the Employer be interpreted to comply in all respects with Section 409A;
provided, however, the Employer shall have no liability to the Executive, or any successor or beneficiary thereof, in the event
taxes, penalties or excise taxes may ultimately be determined to be applicable to any payment or benefit received by the Executive
or any successor or beneficiary thereof.

 

[Remainder of page intentionally left blank]

 

    	 

    	 

    

 

IN WITNESS WHEREOF, this Agreement has been
executed by the Employer and by the Executive as of the Effective Date.

 

	 	EMPLOYER
	 	 
	 	Mandalay Digital Group, Inc., a Delaware corp.
	 	 
	 	By:	/s/ Jeff Karish
	 	Its:	Director, Chairman of Compensation Committee of the Board
	 	 
	 	EXECUTIVE
	 	 
	 	/s/ Peter Adderton
	 	Name: Peter A. Adderton

 

    	 

    	 

    

 

Schedule A

 

		1)	If Executive is the Chief
                                                               Executive Officer for the entire Performance Period, he shall be
                                                               entitled to an annual bonus with respect to the first year of the
                                                               Term as follows:

 

		a.	Definitions:

 

		i.	 	Performance Period: The completed four quarter
period commencing on the beginning of the third fiscal quarter of 2014 (i.e., starting October 1, 2013) and ending at the conclusion
of the second fiscal quarter of fiscal year 2015 (i.e., Q3 + Q4 of FY2014 and Q1 + Q2 FY2015).

 

		ii.	 	Revenue: Revenue as reported in the applicable
quarterly and annual reports filed by the Employer with the Securities and Exchange Commission.

 

		iii.	 	EBITDA: EBITDA as described under SEC rules and
interpretations. For clarity, EBITDA shall be determined after any accrual for or payments of any bonuses or compensation,
including without limitation amounts due or to be due under this Agreement, even though management projections are BEFORE such
accruals and payments and have other adjustments that may not normally be part of EBITDA.

 

		iv.	 	Adjusted “12 Month Target EBITDA”
means the amounts stated as “EBITDA” on the management projection for Q3 and Q4 of FY 2014 and approved by the Board
on August 19, 2013, increased by the amount of any expense or cost that was excluded from the management projections but would
not have been excluded from EBITDA as defined herein. As an example, bonus and compensation accrual and expense is not
excluded from EBITDA (i.e., EBITDA is after such items), but the management projections excluded bonus and compensation accrual
and expense (i.e., the management projection was before such items); in this case, since bonus and compensation would not have
been excluded from EBITDA as defined herein, such amounts must be added back to the management projections in order to determine
Adjusted “12 Month Target EBITDA.” Similarly, if there are other non-cash charges that were excluded from the management
projections but would not be excluded from EBITDA as defined herein, such charges must be added back to determine Adjusted “12
Month Target EBITDA,” having the effect of raising the target EBITDA the Employer would need to achieve for the applicable
bonus amount to be earned, as described below.

 

		b.	Amount: Up To 150% of annual Salary.

 

    	 

    	 

    

 

		c.	Bonus Criteria: There are six (6) bonus criteria,
each worth 25% of Salary. For example, if all six bonus criteria are achieved, the annual bonus for the applicable year shall
be 150% of Salary. If only three (3) bonus criteria are achieved, the annual bonus for the applicable year shall be 75% of Salary.
If none are achieved, then the annual bonus for the applicable year shall be 0% of Salary.

 

		i.	 	25% of Salary if the Employer has publicly reported revenues
for the Performance Period at least equal to the “12 Month Target Baseline Revenue” budgeted amounts for Q3 &
Q4 of FY2014 previously approved by the Board on August 19, 2013 plus the Q1 & Q2 of FY2015 revenues projections to
be provided by management and agreed and approved by the Board; plus

 

		ii.	 	25% of Salary if the Employer has publicly reported revenues
for the Performance Period equal to 125% of the minimum revenue required to achieve the bonus amount in (i) above; plus

 

		iii.	 	25% of Salary if the Employer has EBITDA for the Performance
Period at least equal to the Adjusted “12 Month Target EBITDA” plus the Q1 & Q2 of FY2015 EBITDA projection
to be provided by management and agreed and approved by the Board; plus

 

		iv.	 	25% of Salary if in addition to achieving the bonus amount
in (iii) above, the Employer’s EBITDA for the Performance Period is $3 million more than the minimum EBITDA needed to achieve
the bonus amount in (iii) above; plus

 

		v.	 	25% of Salary if the Executive achieves the following
strategic objectives as reasonably determined by the Compensation Committee of the Board of Directors:

 

		1)	Setting up a structured team acceptable to the Board of Directors of a CEO (assuming the Board of Directors requests a Change
of Capacity), COO, CFO, GC, and other key executive functions in place;

 

		2)	Consolidating the corporate geographic control structure; and

 

		3)	Closing at least five (5) of major carrier relationships generating at least $1 million in annual run-rate revenues; plus

 

		4)	25% of Salary in the sole discretion of the Compensation Committee of the Board.

 

		5)	If the Employer disposes of or acquires a business or material assets during the Performance Period, the revenue and EBITDA
metrics shall be adjusted by the Employer and Executive, acting reasonably, to reflect the change in circumstances.

 

    	 

    	 

    

 

		2)	If Executive remains Chief Executive Officer for—

 

		a.	the entire second year of the Term, then with respect
to the second year of the Term he shall be entitled to an annual bonus that is the same bonus opportunity as for the first year
of the Term (i.e., up to 150% of Salary), with the substantially same structure and same six (6) factors each worth 25% of Salary,
but with revenue and EBITDA milestones for the four fiscal quarters sequentially following the Performance Period adjusted upward
to such levels, and new strategic objectives, each as determined by the Board of Directors and Executive within sixty (60) days
of commencement of the second year of the Term as Chief Executive Officer.

 

		b.	any portion of the second year of the Term but not the
entire second year of the Term and serves the balance of the second year of the Term as Chief Innovation Officer, then his bonus
shall be determined applying the applicable bonus criteria for the CEO and CIO portion of the second year on a pro-rata basis,
as reasonably determined by the Board of Directors.

 

		3)	If a Change of Capacity occurs, and Executive is the Chief Innovation Officer for the remainder of the Term after the Chance
of Capacity, he shall be entitled to an annual bonus with respect to such period as follows:

 

		a.	Amount: Up To 100% of annual Salary.

 

		b.	Bonus Criteria: There are two (2) bonus criteria,
each worth 50% of Salary.

 

		i.	 	50% of Salary if the Employer achieves Board of Directors-defined
performance targets for publicly reported revenues and EBITDA (as defined above in this Schedule A) for the four fiscal quarters
sequentially following the Performance Period, such targets to be determined within sixty (60) days of the Change in Capacity
after consultation with the Executive.

 

		ii.	 	50% of Salary if the Executive meets bonus targets specific
to the CIO role determined by the Board of Directors, such targets to be determined within sixty (60) days of the Change in Capacity
after consultation with the Executive.

 

    	 

    	 

    

 

Schedule B

 

CALIFORNIA LABOR CODE SECTION 2870

INVENTION ON OWN TIME-EXEMPTION FROM AGREEMENT

 

“(a)          Any
provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights
in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time
without using the employer's equipment, supplies, facilities, or trade secret information except for those inventions that either:

 

(1)         Relate
at the time of conception or reduction to practice of the invention to the employer's business, or actually or demonstrably anticipated
research or development of the employer; or

 

(2)         Result
from any work performed by the employee for the employer.

 

(b)          To
the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from
being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.”

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}]]